David Barbie, MD
Dr. Barbie obtained an AB from Harvard College in 1997 and MD from Harvard Medical School in 2002. He completed his residency in internal medicine at Massachusetts General Hospital in 2005, followed by a year as medical chief resident in 2006.
Dr. Barbie was a medical oncology fellow in the Dana-Farber/Partners CancerCare program, which he completed in 2008. Following a post-doctoral fellowship in Dr. William Hahn’s lab at the Broad Institute, he received a tenure-track independent investigator position in 2010 at Dana-Farber, and a clinical position within the Lowe Center for Thoracic Oncology.
His research focuses on novel approaches to targeted therapy for KRAS-driven lung cancer and development of ex vivo models to enhance precision immune-oncology. He has been the recipient of a K08 grant from the NIH, a V Scholar Award from the V Foundation, and grants from Uniting Against Lung Cancer and Friends of the Dana-Farber Cancer Institute, and is currently PI/co-PI on an NIH R01, U01, and P01 award.